Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buckberg vs Del Nido Cardioplegia in Isolated Myocardial Revascularization Surgery
2023-505855-32-01Phase 4Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Feb 2024
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis and cardiac ischemia comparing Buckberg cardioplegia with Del Nido cardioplegia (2 arms). Primary endpoints: Markers of myocardial damage and Operative mortality. Planned start Feb 2024; status: authorised.
02
Drugs
Buckberg cardioplegiadel Nido cardioplegia
03
Conditions
coronary arteriosclerosiscardiac ischemia
Beyond the preview
Go deeper on 2023-505855-32-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505855-32-01.